Market Cap (In JPY)
37.3 Billion
Revenue (In JPY)
40.88 Billion
Net Income (In JPY)
3.43 Billion
Avg. Volume
114.67 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1089.0-2060.0
- PE
- -
- EPS
- -
- Beta Value
- 0.258
- ISIN
- JP3816200004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Takayuki Iwai
- Employee Count
- -
- Website
- https://www.fujipharma.jp
- Ipo Date
- 2010-02-22
- Details
- Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
More Stocks
-
ICCHICC Holdings, Inc.
ICCH
-
WLFD
-
301163
-
1245
-
KARNAVATIKarnavati Finance Limited
KARNAVATI
-
ADUS
-
017940E1 Corporation
017940
-
BC-PC